Your browser doesn't support javascript.
loading
Ketamine vs midazolam: Mood improvement reduces suicidal ideation in depression.
Hochschild, Annabella; Keilp, John G; Madden, Sean P; Burke, Ainsley K; Mann, J John; Grunebaum, Michael F.
Afiliação
  • Hochschild A; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, and Columbia University Irving Medical Center, New York, NY.
  • Keilp JG; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, and Columbia University Irving Medical Center, New York, NY.
  • Madden SP; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, and Columbia University Irving Medical Center, New York, NY.
  • Burke AK; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, and Columbia University Irving Medical Center, New York, NY.
  • Mann JJ; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, and Columbia University Irving Medical Center, New York, NY.
  • Grunebaum MF; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, and Columbia University Irving Medical Center, New York, NY. Electronic address: Michael.grunebaum@nyspi.columbia.edu.
J Affect Disord ; 300: 10-16, 2022 03 01.
Article em En | MEDLINE | ID: mdl-34953926

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article